• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


Price not available for TGXSF:US

Snapshot for TiGenix NV (TGXSF)

Open: - Day's Range: - Volume: 0
Previous Close: 0.7500 52wk Range: 0.3900 - 0.9900 1-Yr Rtn: -

Stock Chart for TGXSF

No chart data available.
  • TGXSF:US 0.7500
  • 1M
  • 1Y
Interactive TGXSF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TGXSF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.1030
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 160.48
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TGXSF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for TGXSF

TiGenix N.V. is a biomedical company focused on cell therapy. The Company researches and develops treatments for autoimmune and inflammatory diseases.

Eduardo Bravo Fernandez De AraozCEO/Managing DirectorClaudia D AugustaCFO/Secy/Compliance Officer
Wilfried DalemansChief Technology OfficerMarie Paule RichardChief Medical Officer
More Company Profile & Key Executives for TGXSF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil